Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-11-28
2006-11-28
Saeed, Kamal A. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S318000, C546S269700, C546S187000
Reexamination Certificate
active
07141588
ABSTRACT:
The present invention provides antibacterial agents having the formulae I, II, and III described herein.
REFERENCES:
patent: 4705799 (1987-11-01), Gregory
patent: 5043443 (1991-08-01), Carlson et al.
patent: 5164510 (1992-11-01), Brickner
patent: 5182403 (1993-01-01), Brickner
patent: 5225565 (1993-07-01), Brickner
patent: 5231188 (1993-07-01), Brickner
patent: 5247090 (1993-09-01), Brickner
patent: 5523403 (1996-06-01), Barbachyn
patent: 5529998 (1996-06-01), Habich et al.
patent: 5547950 (1996-08-01), Hutchinson et al.
patent: 5565571 (1996-10-01), Barbachyn et al.
patent: 5614535 (1997-03-01), Juraszyk et al.
patent: 5627181 (1997-05-01), Riedl et al.
patent: 5652238 (1997-07-01), Brickner et al.
patent: 5684023 (1997-11-01), Riedl et al.
patent: 5688792 (1997-11-01), Barbachyn et al.
patent: 5698574 (1997-12-01), Riedl et al.
patent: 5792765 (1998-08-01), Riedl et al.
patent: 5827857 (1998-10-01), Riedl et al.
patent: 5843967 (1998-12-01), Riedl et al.
patent: 5861413 (1999-01-01), Häbich et al.
patent: 5869659 (1999-02-01), Stolle et al.
patent: 5952324 (1999-09-01), Barbachyn et al.
patent: 5968962 (1999-10-01), Thomas et al.
patent: 5981528 (1999-11-01), Gravestock
patent: 5990136 (1999-11-01), Barbachyn et al.
patent: 6043266 (2000-03-01), Ennis et al.
patent: 6051716 (2000-04-01), Hutchinson et al.
patent: 6069145 (2000-05-01), Betts
patent: 6069160 (2000-05-01), Stolle et al.
patent: 6110936 (2000-08-01), Gravestock
patent: 6166056 (2000-12-01), Thomas et al.
patent: 6194441 (2001-02-01), Roberts et al.
patent: 6239152 (2001-05-01), Gordeev et al.
patent: 6239283 (2001-05-01), Gage
patent: 6271383 (2001-08-01), Gravestock
patent: 6313307 (2001-11-01), Ennis et al.
patent: 6919329 (2005-07-01), Thomas et al.
patent: 417044 (1990-08-01), None
patent: 697408 (1995-08-01), None
patent: WO94/01110 (1994-01-01), None
patent: WO95/07271 (1995-03-01), None
patent: WO95/25106 (1995-09-01), None
patent: WO96/13502 (1996-05-01), None
patent: WO96/15130 (1996-05-01), None
patent: WO96/23788 (1996-08-01), None
patent: WO96/35691 (1996-11-01), None
patent: WO97/09328 (1997-03-01), None
patent: WO97/30995 (1997-08-01), None
patent: WO98/54161 (1998-12-01), None
patent: WO99/03846 (1999-01-01), None
patent: WO99/29688 (1999-06-01), None
patent: WO99/37641 (1999-07-01), None
patent: WO99/37652 (1999-07-01), None
patent: WO99/40094 (1999-08-01), None
patent: WO99/64417 (1999-12-01), None
patent: WO00/21960 (2000-04-01), None
patent: WO00/44741 (2000-08-01), None
patent: WO00/73301 (2000-12-01), None
patent: WO01/40236 (2001-06-01), None
patent: WO01/46185 (2001-06-01), None
patent: WO01/81350 (2001-11-01), None
patent: WO02/059155 (2002-08-01), None
patent: WO02/096916 (2002-12-01), None
patent: WO03/006440 (2003-01-01), None
Abdelaal, et. al., “Synthesis of 1-[3-Methyl]-2(3H)-benzazolon-5- or 6-yl]-4{4-[cis-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl-methyl)-1,3-dioxolan-4-yl]methyleneoxyphenyl]}piperazines” Journal of Heterocyclic Chem., 29, 1069, (1992).
Barbachyn, et. al. “Identification of a Novel Oxazolidinone(U-100480)with Potent Antimycobacterial Activity.” Journal of Medicinal Chemistry. 1996, 39, 680-685.
Blache, et. al. “Application of the Mercuric Acetate-Edetic Acid Oxidation Method To The Synthesis of 11-Aza-1,2,3,4,5,6,7,12bpOctahydroindolo[2,3-α]Quinolizines.” Heterocycles, vol. 45, No. 1, pp. 57-69, 1997.
Bodor, Nicholas and J. Hillis Miller, “Novel Approaches in Prodrug Design.” Drugs of the Future vol. VI, No. 3, 1981, pp. 165-182.
Brickner, Steven J. “Oxazolidinone Antibacterial Agents.” Current Pharmaceutical Design. 1996, 2, 175-194.
Brickner, et. al. “Synthesis and Antibacterial Activity of U-100592 and U-100766, Two Oxazolidinone Antibacterial Agents for the Potential Treatment of Multidrug-Resistant Gram-Positive Bacterial Infections.” Journal of Medicinal Chemistry. 1996, 39, 673-679.
Bundgaard, Hans. “Design of prodrugs: Bioreversible derivatives for various functional groups and chemical entities.” Design of Prodrugs, Chapter 1, 1985.
Cava, Michael P. and Matthew I. Levinson. “Thionation Reactions of Lawesson's Reagents.” Tetrahedron vol. 41, No. 22, pp. 5061-5087, 1985.
Clark, Robert L. and Arsenio A. Pessolano. “Synthesis of Some Substituted Benzoxazolones.” Journal of the American Chemical Society. vol. 80, pp. 1662, 1958.
Comins, et al. “Preparation of 2,6-Disubstituted 2,3-Dihydro-4-pyridones: Dehydrogenation of Trimethylsilyl Enol Ethers with Palladium(II)Acetate.” Tetrahedron Letters, vol. 36, No. 52, pp. 9449-9452, 1995.
Comins, et al. “Regio- and Stereoselective Addition of Nucleophiles to 1- Phenoxycarbonyl-2,3-Dihydropyridium Salts.” Heterocycles, vol. 37, No. 2, 1994.
Dehmlow, Eckehard, and Ralf Westerheide. “Studies Towards 3,4-Dimethoxy-1-Methyl-1,2-Dihydropyridine, so-called Arecolidine, or its Tautomers.” Heterocycles, vol. 37, No. 1, 1994.
Diez, et al. “Preparation of a New Chiral 5,6-Dihydropyridinium Synthon.” Heterocycles, vol. 31, No. 3, 1990.
Dodd, Dharmpal and Allan Oehlschlager. “Efficient Route to the Synthesis of C-2, C-3 Substituted 4-Piperidones.” Tetrahedron Letters, vol. 32, No. 30, pp. 3643-3646, 1991.
Evans, et. al. “Regioselective Preparation of α,β-Unsaturated Ketones via the Direct Dehydrogeantion of Triisopropylsilyl Enol Ethers.” Tetrahedron Letters, vol. 36, No. 23, pp. 3985-3988, 1995.
Gage, et. al. “Stereodivergent synthesis of sulfoxide-containing oxazolidinone antibiotics.” Tetrahedron Letters, 41 (2000) 4301-4305.
Guerry, Philippe and Reinhard Neier, “Photochemical Cycloadditions to 5,6-Dihydro-4-pyridones.” Chimia 41 (1987) No. 10 (Oct.).
Guerry, Philippe and Reinhard Neier. “Reduktion von 4-Pyridinonen.” Synthesis, Jun. 1984 pp. 485-488.
Haider, et. al. “140. Synthesis of 4-Oxo-1,2,3,4-tetrahydropyridine(2,3-Dihydro-4(1H)pyridinone),” Helvetica Chimica Acta—vol. 58, Fasc. 5 (1975)—Nr. 139-140 pp. 1287-1292.
Herrinton, et. al. “Iodination and Metal Halogen Exchange of Aromatic Compounds: An Improved Preparation of a Key Oxazolidinone Antibiotic Intermediate.” Organic Process Research and Development 2001, 5, 80-83.
Ishii, et. al. “Rhodium-Catalyzed Reaction of N-Acylpiperazines with CO and Ethylene, Carbonylation at a C-H Bond Directed by an Amido Group.” Tetrahedron Letters, vol. 38, No. 43, pp. 7565-7568, 1997.
Kirschbaum, Stephen, and Herbert Waldmann. “Construction of the Tricyclic Benzoquinolizine Ring System by Combination of a Tandem Mannich-Michael Reaction with a Heck Reaction.” Tetrahedron Letters, vol. 38, No. 16, pp. 2829-2832, 1997.
Kirschbaum, Stepen, and Herbert waldmann. “Three-Step Acces to the Tricyclic Benzo[α]quinolizine Ring System.” Journal of Organic Chemistry. 1998, 63, 4936-4946.
Lock, Ralf, and Herbert Waldmann. “Asymetric Synthesis of Highly Functionalized Tetracyclic Indole Bases Embodying the Basic Skeleton of Yohimbinep and Reserpine Type Alkaloids.” Tetrahedron Lett rs, vol. 37, No. 16, pp. 2753-2756, 1996.
Lock, Ralf, and Herbert Waldmann. “Enantioselective Construction of Highly Fuctionalized Indoloquinolizines Congeners to Polycyclic Indole Alkaloids.” Chem. Eur. J. 1997, 3, No. 1, pp. 143-151.
Mai, et. al. “N-[4-(1,1′-Biphenylyl)Methyl]-4-(4-Thiomorpholinylmethyl)Benzenamines, a New Class of Synthetic Antituberculosis Agents Active Against Mycobacterium Avium.” Medicinal Chemistry Research, 9:3 (1999) 149-161.
Notari, Robert E., “Theory and Practice of Prodrug Kinetics.” Methods in Enzymology, vol. 112, 1985, pp. 309-323.
Reggelin, Michael and Cornelia Zur, “Sulfoximines; Structures, Properties and Synthetic Applications.” Synthesis, 2000, No. 1, 1-64.
Roush, William R., and Bradley B. Brown. “Enantioselective Syntehsis of 2-Alkyl-5-methyl
Barbachyn Michael Robert
Gordeev Mikhail Fedor
Josyula Vara Prasad Venkata Nagendra
Luehr Gary W.
Poel Toni-Jo
Ashbrook Charles W.
Baude Eric J.
Pfizer Inc.
Saeed Kamal A.
Yang Lucy X.
LandOfFree
N-aryl-2-oxazolidinone-5-carboxamides and their derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-aryl-2-oxazolidinone-5-carboxamides and their derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-aryl-2-oxazolidinone-5-carboxamides and their derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3624239